Another interesting result that emerges from our data is the confirmation, already seen in previous articles [8,24,25,26,27], that anti-Il-5 and anti-IGE biological therapy have been shown to be effective in reducing blood eosinophilia and in controlling severe asthma, regardless of whether patients also had bronchiectasis not due to CF or ABPA. Here, IL5 is linked to asthma.